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Abstract Five single amino acid substitution variants of EF-Tu 
from Salmonella typhimurlum were tested for their ability to 
promote poly(U)-translation in vitro. The substitutions are 
Leut2°Gln, Gln124Arg and Tyr 16° (Asp or Asn or Cys). They 
were selected by their kirromycin resistant phenotypes and all 
substitutions are in domain I at the interface between domains I
and III of the EF-Tu. GTP configuration. The different EF-Tu 
variants exhibit a spectrum of phenotypes. First, kcat/KM for the 
interaction between ternary complex and the programmed 
ribosome is apparently reduced by the substitutions Leu12°Gln, 
Gln124Arg and Tyrl6°Cys. Second, this reduction is caused by a 
defect in the interaction between these EF-Tu variants and 
aminoacyl-tRNA during translation. Third, in four cases out of 
five the affinity of the complex between EF-Tu" GTP and 
aminoacyi-tRNA is significantly decreased. The most drastic 
reduction is observed for the Gln124Arg change, where the 
association constant is 30-fold lower than in the wild-type case. 
Fourth, missense rrors are increased as well as decreased by the 
different amino acid substitutions. Finally, the dissociation rate 
constant (ka) for the release of GDP from EF-Tu is increased 6- 
fold by the Tyrl6°Cys substitution, but remains unchanged in the 
four other cases. These results show that the formation of ternary 
complex is sensitive to many different alterations in the domain I- 
III interface of EF-Tu. 
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1. Introduction 
Elongation factor Tu (EF-Tu) is a protein of 393 amino 
acids folded into three distinct structural domains [1,2] and 
forms a ternary complex with GTP and aa-tRNA. The tern- 
ary complex participates in protein biosynthesis by mediating 
the interaction of aa-tRNA with the ribosomal A site, accel- 
erating very significantly the rate of aa-tRNA binding to the 
ribosome, and reducing missense rrors by more than 2 orders 
of magnitude. These activities of EF-Tu depend on the nature 
of the bound guanine nucleotide [3]. In its GTP conformation 
EF-Tu has a high affinity for aa-tRNA with an association 
constant in the range of 107 M -1 [4,5]. The (cognate) interac- 
tion between an mRNA codon in the A-site and the anticodon 
of aa-tRNA in ternary complex with EF-Tu.GTP is rapidly 
followed by hydrolysis of GTP on EF-Tu [6]. GTP hydrolysis 
changes the conformation of EF-Tu and causes its subse- 
quent, rapid release from the ribosome. The affinity of EF- 
Tu for aa-tRNA is 2 orders of magnitude lower when the 
factor is in its GDP-rather than its GTP-configuration [7]. 
A second elongation factor, EF-Ts, catalyses the exchange 
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of GDP to GTP on EF-Tu, thus reactivating EF-Tu so that 
it can again bind aa-tRNA and form the translationally active 
ternary complex [8]. 
Mutation studies and physico-chemical nalyses suggest 
that residues in all three domains of EF-Tu influence its bind- 
ing of aa-tRNA. Site-directed mutagenesis of conserved His 
residues in domain I (His 66 and His 118) show that alterations 
at these positions reduce the affinity of EF-Tu for aa-tRNA 
[9,10]. The residues Lys 2°s and Lys 23z in domain II of EF-Tu 
have been crosslinked, in the presence of kirromycin, to 3' 
oxidised tRNA [11]. Residues in EF-I~ equivalent to residues 
(260-263) in domain II of E. coli EF-Tu are crosslinked to, 
and protected from protease digestion by, aa-tRNA [12]. The 
kirromycin resistant tufAa allele in E. coli, Glu3ZSLys in do- 
main III of EF-Tu, is defective in binding aa-tRNA [5,13]. 
Truncated EF-Tu, lacking either domain I, or both domains 
II and III, shows no interaction with aa-tRNA [14,15]. The 
crystal structure of the ternary complex of EF-Tu.GTPc.aa- 
tRNA has recently been solved [16] opening the possibility to 
evaluate at a structural level the effects of mutations in EF-Tu 
on interactions with aa-tRNA. 
Kirromycin, an antibiotic which binds EF-Tu, inhibits the 
release of EF-Tu-GDP from the ribosome [17]. Selections for 
spontaneous kirromycin resistant mutations in Salmonella ty- 
phimurium, have identified 13 different substitutions clustering 
in the domain I-III interface [13]. We have studied the influ- 
ence of five of these mutants in domain I on translation in 
vitro and find significant effects on aa-tRNA binding to EF- 
Tu" GTP as well as on missense rror levels in poly(U)-trans- 
lation. 
2. Materials and methods 
2.1. Chemicals 
Poly(U), GTP, ATP and GDP were purchased from Pharmacia, 
Sweden. Phosphoenolpyruvate (PEP), putrescine, spermidine, myoki- 
nase (MK) (EC 2.7.4.1), pyruvate kinase (PK) (EC.2.7.1.40), L-phe- 
nylalanine and L-leucine were products of Sigma, St Louis, USA. 
[3HI-and [14C]phenylalanine as well as [3H]leucine and [3H]guanosine 
5'-diphosphate w re from Amersham, Bucks, UK. All other chemicals 
of analytical grade were from Merck, Darmstadt, Germany. 
2.2. Buffers 
Polymix buffer [18] contains 5 mM magnesium acetate, 0.5 mM 
CaCI2, 5 mM NH4C1, 95 mM KCI, 8 mM putrescine (pH 7.5), 
1 mM spermidine, 5 mM potassium phosphate (pH 7.3) and 1 mM 
dithioerythritol (DTE). 10 times concentrated polymix buffer (10 × p- 
mix) was prepared and stored without potassium phosphate (to avoid 
precipitation) and DTE. The correct working strength of polymix was 
obtained by adding from stock solutions of 10×pmix, 100 mM po- 
tassium phosphate (20 × KP) and 50 mM DTE in the experiments. 
2.3. Strains and biochemicals 
tRNA Phe, Phe-tRNA Phe synthetase (PRS) and Leu-tRNA Leu 
synthetase (LRS) were purified from E.coli MRE-600 cells according 
S0014-5793/96l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
SSDI S00 1 4-5793(96)00 1 84-6 
298 
to Ehrenberg et al. [19]. Ribosomes, wild-type EF-Tu and EF-G were 
prepared from either E.coli 017 [20] or from S. typhimurium LT2 [21], 
EF-Ts was prepared from 017 and the altered EF-Tu's from LT2 cells. 
Purification procedures and storage conditions are described by 
Ehrenberg et al. [19]. The EF-Tu preparations were modified accord- 
ing to Hughes [22]. 
2.4. EF- Tu concentration 
The purity of all EF-Tu preparations was higher than 95%, as 
judged from SDS-PAGE. The protein content of EF-Tu was esti- 
mated according to Bradford [23]. As protein standard was used an 
EF-Tu with its concentration determined by amino acid analysis. 
Nucleotide xchange assays [4,24], that measure the concentration 
of EF-Tu active in GDP-binding, showed EF-Tu concentrations iden- 
tical with those obtained by the Bradford method. 
2.5. Poly( U)-translation assays 
Poly(Phe)-synthesis rates were measured at 37°C according to 
Ehrenberg et al. [19]. 
2.5.1. Assay 1. kcat and KM values for the interaction between 
ternary complex and ribosomes were obtained from translation assays 
at different EF-Tu concentrations. A factor mix and a ribosome mix 
were separately prepared in polymix buffer. The factor mix contained 
2 mM ATP, 20 mM PEP, 2 mM GTP, 0.6 mM [14C]Phe, and (per 50 
gl) 5 lag PK, 0.3 gg MK, 100 pmol EF-Ts, 200 pmol EF-G, 700 pmol 
tRNA phi, 200 units PRS (one unit of PRS charges one pmol of 
tRNA phe per s). 10 lal aliquots of EF-Tu dilutions (10 300 pmol) in 
polymix buffer were added to 50 lal aliquots of the factor mix. The 
ribosome mix contained (per 40 lal) 10 pmol of ribosomes active in 
elongation, 50 pmol NAc-[aH]Phe-tRNA ph~ and 20 lag poly(U). Factor 
and ribosome mixes were pre-incubated at 37°C for 10 min. 
Translation was started by adding 40 lal of ribosome mix to each of 
the factor mixes. After incubation times in the range 5 25 s, chosen to 
make the poly(Phe) chains of similar length at different elongation 
rates [19], the reactions were stopped by addition of 5 ml 5% TCA. The 
samples were then analysed for extent of poly(Phe) synthesis (from 
[14C]Phe) and for amount of elongating chains (from NAc-[aH]Phe) 
[19,251. 
2.5.2. Assay 2. Determination f translation rates at different con- 
centrations ofPhe-tRNAPh% Separate factor and ribosome mixes were 
prepared as in assay 1, except hat the amount of EF-Tu in the factor 
mix now was fixed at 10 pmol, while that of Phe-tRNA ~he was varied 
from 50 to 2000 pmol and the assay incubation times were varied in 
the range 10-30 s [4,5]. 
2.6. Binding constant for the complex between aa-tRNA and 
EF- Tu" G TP 
The spontaneous deacylation rate constant for free aa-tRNA (kf) is 
much faster than for aa-tRNA in complex with EF-Tu.GTP (/%) 
[4,5,26,27]. The fraction (TfITo) of free (Tf) divided by total (T0) 
aa-tRNA was estimated from the average deacylation rate constant 
(k), obtained for different total concentrations of EF-Tu.GTP (Tu0) 
at a fixed T0 [4,27]: 
Tf Tb (kf -- kb) • Tf 
k : kf" Too + kb'T00 = T00 + kb 
This relation is valid when the deacylation rate constants kb and kf 
are small in relation to the rate constant for aa-tRNA dissociation 
from EF-Tu. GTP [4,5,27]. Tu/To = (1-Tf/To) is the ratio between aa- 
tRNA bound to EF-Tu.GTP (Tb) and T0. Experimental determina- 
tion of kf, kb and k values at each point in the EF-Tu titration 
(specified below) gives TflTo and Tb/To as 
Tf k -  kb Tb kf -- k 
To -- kf -- kb' To kf -- kb 
2.6.1. Deacylation protection assay. A tRNA charging mix was 
prepared on ice in polymix buffer. It contained 0.3 mM [t~C]Phe, 
1 mM ATP, 10 mM PEP, 1 mM GTP, and (per 80 lal) 5 lag PK, 
0.3 lag MK, 4 units of PRS, and either 100 pmol of Phe-tRNA ph" (for 
wild-type and the EF-Tu variant Tyr16°Asp), or 400 pmol of Phe- 
tRNA phe (for the EF-Tu variants Tyrlr°Asn, Tyr16OCys, Gln~2aArg 
and Leul2°Gln). For binding in the presence of kirromycin (dissolved 
in 0.5% methanol) the charging mix contained 1000 pmol (w.t. EF- 
Tu) or 10000 pmol (EF-Tu variants 12°Gln and 16°Cys) kirromycin. In 
control assays only methanol or only polymix buffer were added in- 
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stead of kirromycin. Aliquots of EF-Tu (10 lal) containing 0-1400 
pmol (w.t., Tyrlr°Asp) or 0-3000 pmol (Tyrl~°Asn, Tyrlr°Cys, 
Gln124Arg, Leu12°Gln) were added to the charging mixes (80 gl). 
Then, the mixes were preincubated for 5 min at 37°C for full charging 
of tRNA with [14C]Phe. Incubation was started by adding 10 gl (100 
pmol) of [:~H]Phe to each charge mix. The reactions were stopped after 
20 min by adding 5 ml ice-cold 5% TCA, and the samples were 
analysed for the amounts of tRNA charged with [SH]Phe and [14C]Phe. 
The amount of [aH]Phe-tRNAPh~ (ah) increases with the incubation 
time T as 
ah = o,." (1 -- e kT) 
The level, a~, of [14C]Phe-tRNA phe was constant throughout the 
incubation time T, in contrast to earlier methods [27], because deacy- 
lation was immediately followed by reacylation with [~4C]Phe and 
[aH]Phe. The [aH]Phe, added at the start of incubation, had high 
specific activity and much lower concentration than [14C]Phe. 
Measurement of a~ and ah at the incubation time T gives k as 
1 " ln (1 - -  a22) k -  T 
Calibration of the specific activities of [14C]Phe and [aH]Phe, to 
obtain ah/a~ as pmol [aH]Phe per pmol [14C]Phe, was performed by 
aminoacylating tRNA phe with the [14C]Phe and [3H]Phe amino acids 
mixed already at the start of the aminoacylation reaction. 
Accurate values of k were obtained also for small values of ah/ao, 
which significantly reduced the incubation time T in relation to pre- 
vious techniques [27]. In addition, the constant [14C]Phe charging level 
a~. led to simple and accurate data evaluation. 
2. 7. Missense rror rates in vitro 
Missense rror rates were measured in EF-Tu-GTP titrations with 
bulk tRNA, where Leu-tRNA Leu competes with Phe-tRNA Phe in 
poly(U)-translation. 
2.7.1. Factor mixes. Factor mixes were prepared on ice in bal- 
anced polymix buffer with 2 mM GTP, 20 mM PEP, 2 mM ATP, 
0.6 mM [14C]Phe, 0.08 mM [3H]Leu and (per 50 lal) 5 lag MK, 0.3 lag 
PK, I00 pmol EF-Ts, 200 pmol EF-G, 100 pmol tRNA Phe, 200 pmol 
tRNA Leu, 100 units PRS, 10 units LRS. To 50 gl aliquots of these 
mixes were added 10 lal aliquots of EF-Tu (5~1200 pmol) in polymix 
buffer. The mixes were preincubated for 10 min at 37°C. 
2.7.2. Ribosome mixes. One ribosome mix was prepared on ice as 
in section 2.5 with NAc-[14C]Phe-tRNA Ph° replacing NAc-[3H]Phe - 
tRNAPh% A second ribosome mix, where polymix buffer replaced 
poly(U), was prepared for missense error backgrounds. The ribosome 
mixes were preincubated for 10 min at 37°C. 
2.73. Missense rror assay. Translation was started by adding 40 
lal aliquots from the ribosome mix to each factor mix (60 lal). After 
30 s incubation at 37°C the reactions were stopped by 5 ml 5% TCA, 
and the samples analysed according to Ehrenberg et al. [19]. 
2.7.4. RNA charging. For charging determinations, factor mixes 
(50 lal) were prepared as above, but without EF-Tu and with either 
LRS (for Phe-tRNA ph~ levels) or PRS (for Leu-tRNA L~ levels) re- 
placed by polymix buffer, to eliminate spillover between the ~4C and 
3H channels of the counter. After 10 min incubation, charging levels 
were measured as in section 2.6 [19]. 
3. Results 
3.1. Translation rate as a funct ion o f  EF -Tu  concentration 
Titrations were made with wild-type and mutant species of 
EF-Tu at a constant ribosome concentration (10 pmol active 
in 100 p.1). The maximum rate for the complete ribosome cycle 
(kc~t) is similar for all studied variants of EF-Tu, and was 
close to 10 amino acids per ribosome per second (Fig. 1). 
The kcat/KM value for ternary complex association with the 
ribosome is similar for the wild-type and the EF-Tu mutants 
16°Asp and 16°Asn at close to 1.7× l07 (M -1 s -1) (Fig. 1A, 
Table 1). However, the other mutant EF-Tu's tested, 16°Cys, 
124Arg and 12°Gln, apparently have significantly reduced kcat/ 
KM values (1.25, 0.8, and 0.8 × 107 M -1 s - I ,  respectively) (Fig. 
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Fig. 1. Eadie-Hofstee plots for the rate of elongation (v) of poly(U) 
translating ribosomes for different otal concentrations of EF-Tu 
(Tu0). v is the extent of poly(Phe) synthesis (measured from hot 
TCA precipitable [t4C]Phe) normalized to the number of poly(Phe) 
chains (measured from hot TCA precipitable NAc-[3H]Phe) and di- 
vided by the actual incubation time (section 2). The intercept at the 
y-axis gives kcat and the intercept at the x-axis gives keat/KM for 
poly(Phe) elongation. (A) Wild-type and the EF-Tu variants 16°Asp, 
16°Asn and 16°Cys, (B) Wild-type and the variants 124Arg and 
120Gln. 
1A,B and Table l). Further analyses were carried out to in- 
vestigate if it is the association between ternary complex and 
the ribosome which is affected by the mutations, or whether 
they cause a defect in binding of aa-tRNA to EF-Tu.GTP. 
3.2. Translation as a function of  tRNA concentration 
This assay was made to test whether the apparent reduction 
in k~t/KM values for some of the mutant ternary complex 
interactions with the ribosome could be overcome by increas- 
ing the concentration of aa-tRNA, which could enhance the 
fraction of EF-Tu in the ternary complex in spite of a per- 
turbed binding. The assays were carried out for w.t. EF-Tu 
and for the variants 12°Gln, 124Arg, 16°Cys, which showed 
apparent defects in k~,t/KM (section 3.1). Translation was 
run at fixed, low concentrations of EF-Tu (10 pmol per 100 
gl), and varied concentrations of Phe-tRNA Phe (50-2000 pmol 
per 100 gl). In each case, titration to high values of aa-tRNA 
abolished the apparent defect in ternary complex interaction 
with the ribosome (Fig. 2). This shows that the major defect 
of these mutants i  in the binding of aa-tRNA to form ternary 
complex. 
3.3. Binding of  EF-Tu. GTP to aa-tRNA 
To test more directly defects in the binding of aa-tRNA by 
the mutant EF-Tu's we measured equilibrium binding con- 
stants (section 2). In the Scatchard [28] plots in Fig. 3, the 
equilibrium binding constant between EF-Tu. GTP and aa- 
tRNA is the intercept on the y-axis, while the apparent stoi- 
chiometry (n) of EF-Tu.GTPs bound to aa-tRNA is the in- 
verse of the intercept on the x-axis. The association constant 
(KA) for wild-type EF-Tu.GTP and Phe-tRNA phe is 
0.75x 107 M -1 (Fig. 3A) and the stoichiometry, n is close 
to 2, in agreement with published values [4,5]. In contrast, 
KA for wild-type EF-Tu. GDP is about 200-fold lower and 
is only 0.37 105 M -1, confirming earlier results [7,27,29] and 
demonstrating the importance of the EF-Tu-GTP form for 
the interaction with aa-tRNA. Kirromycin increases the asso- 
ciation constant KA about 2-fold (KA = 1.32 107 M-l). At the 
same time, no effect of kirromycin on the KA values for the 
mutants lZ°Gln and 16°Cys was observed. In addition, we 
found that even very high concentrations of EF-Tu" GDP'kir- 
romycin complex (2 x 10 -s M) did not protect aa-tRNA from 
deacylation. 
The mutant 16°Asp has a KA value of 0.71 × 107 M -1, as in 
the wild-type case. The mutants ]a°Asn and 16°Cys have asso- 
ciation constants reduced to 0.4 and 0.25 x 107 M -], respec- 
tively (Fig. 3B, Table 1). The most severe defects were seen 
with the mutants 12°Gln and 124Arg, where KA is reduced to 
0.12 and 0.025 × 107 M -1, respectively (Fig. 3C, Table 1). The 
association constant for the mutant ]24Arg was too weak to 
give an accurate Scatchard value, and was therefore stimated 
with the stoichiometry n fixed and equal to 2, as found for the 
other EF-Tu variants (Fig. 3C). 
3.4, Missense errors 
Missense rrors were calculated from the frequency of the 
incorporation of near cognate Leu-tRNA Leu in response to 
poly(U)-programmed ribosomes and in competition with 
Phe-tRNA phe (section 2). In titrations with EF-Tu any differ- 
ences in the ability of the competing aa-tRNA's (tRNA 5eu 
and tRNA phe) to form ternary complex will eventually be 
overcome at high EF-Tu concentrations. Thus, at low levels 
of EF-Tu variations in error may reflect competition by the 
Table 1 
(A) Binding of aa-tRNA to EF-Tu.GTP, and (B) kcat/KM of the 
ternary complex ribosome interaction 
EF-Tu variant (A) KA X 10-7 (B) kcat/KM X 10-7 
(M -1) (M -I s -1) 
WT(GTP) 0.75 1.8 
WT(GDP) 0.0037 
WT(GTP.Kir) 1.32 
16°Asp 0.71 1.8 
16°Asn 0.4 1.7 
16°Cys  0 .25  1.25 
124Arg 0.025 0.8 
~°Gln 0.12 0.8 
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Fig. 2. Eadie-Hofstee plots for the rate of elongation (v) at limiting 
EF-Tu concentration (10 ~ M) at different concentrations of Phe- 
tRNA phe for wild-type EF-Tu and for the variants 16°Cys, ~24Arg 
and 12°Gln. v is determined as in Fig. 1. The intercept at the y-axis 
shows the rate of poly(Phe) elongation at a rate-limiting EF-Tu 
concentration and at saturating concentrations of Phe-tRNA Ph°, 
where differences in tRNA binding to the different EF-Tu variants 
are eliminated. The common intercept in all four cases (only one is 
shown for clarity) shows that the deficiency in koJKM for these 
three EF-Tu variants (Fig. 1) is caused by inefficient ternary com- 
plex formation and not by impaired interaction by the correspond- 
ing ternary complexes and the ribosome. The intercept at the x-axis 
shows how the interaction between aminoacyl-tRNA and the differ- 
ent EF-Tu variants affects poly(Phe) synthesis at rate-limiting con- 
centrations of Phe-tRNA Ph~ and EF-Tu. 
aminoacyl-tRNAs for EF-Tu to form active ternary complex. 
At high levels of EF-Tu, in contrast, the error level only 
reflects the relative fficiency by which cognate and non-cog- 
nate ternary complexes compete for the poly(U)-programmed 
ribosome. The error rate associated with the wild-type EF-Tu 
was estimated to be 5× 10 -4, in agreement with published 
values [25,30]. For the mutants of EF-Tu the pattern is quite 
complex. For all concentrations of EF-Tu, 16°Cys and 16°Asp 
have reduced error levels (2 and 3 × 10 -4, respectively) (Fig. 
4A), 124Arg has a wild-type error level (5 × 10 -4) and 12°Gln 
has an increased error level (9×10 -4) (Fig. 4B). The con- 
stancy of these error levels at varying EF-Tu concentrations 
indicates that in these cases the affinities of Leu-tRNA L'u and 
Phe-tRNA ehe to EF-Tu are quite similar. In contrast, 16°Asn 
has error levels which increase with increasing EF-Tu concen- 
trations, indicating that this EF-Tu variant has a significantly 
lower affinity for the Leu-tRNA Le" than for Phe-tRNAPh% 
16°Asn has an error level of more than 10 -3 at saturating 
EF-Tu concentrations (Fig. 4A). This suggests that this muta- 
tion not only weakens the binding of Leu-tRNA Leu to EF-Tu 
in relation to the binding of Phe-tRNA ph~ to the factor (the 
errors increase significantly with increasing EF-Tu concentra- 
tion in contrast to the wild-type case where they are approxi- 
mately constant), but also makes ternary complex with Leu- 
tRNA L~u a more efficient competitor to Phe-tRNA phi' con- 
taining ternary complex in poly(U)-translation. 
One of the EF-Tu variants, 16°Cys, has a GDP exchange 
rate constant hat is significantly higher than for wild-type 
EF-Tu (0.06 and 0.01 s 1, respectively), showing that amino 
acid substitutions at the interface between domains I and III 
may, conditionally, affect the binding of GDP to EF-Tu. Each 
of the other four mutant EF-Tu's has a GDP exchange rate 
which is not significantly different from the wild-type. 
4. Discussion 
Substitution mutations at three amino acid sites in domain I 
of EF-Tu, Leu 12°, Gln 124, TyP 6° give rise to a kirromycin 
resistant phenotype [13]. The side chains of these three amino 
acids are aligned and in contact, Gln with Leu and Leu with 
Tyr, and all point into the domain I-III interface in both the 
GTP and GDP conformations of EF-Tu [1,31]. In an EF-Tu- 
limited translation elongation assay under standard conditions 
[19] three of the mutants, a2°Gln, 124Arg, and a6°Cys have an 
apparently reduced kcat/KM for the interaction of cognate 
ternary complex with the ribosome during translation (Fig. 
1B, Table 1). Mutants in EF-Tu can exert such effects either 
by influencing the efficiency with which ternary complex is 
formed, or the rate at which ternary complex interacts with 
and delivers aa-tRNA to the ribosome. This apparent kcat/KM 
reduction could in all cases be reversed by enhancing the 
concentration f Phe-tRNA phe, showing that the defect caus- 
ing it in each of these mutants (12°Gln,~24Arg and16°Cys) is in 
the formation of ternary complex, rather than in the cognate 
interaction between ternary complex and the ribosome. 
We probed this defect more directly by measuring the equi- 
librium binding constant between each of the mutant EF-Tu's 
and Phe-tRNAPh% The substitution mutations 16°Asn and 
16°Cys reduce somewhat he binding to Phe-tRNA Phi, but 
the most dramatic effects are caused by 12°Gln and 124Arg: 
their association constants are reduced to one eighth and one 
thirtieth, respectively, of the wild-type level (Fig. 3). The mag- 
nitude of these binding effects is consistent with the relative 
magnitude of the effects seen with these mutants in the trans- 
lation assays (Fig. 2). 
It is known from previous work that substitutions of the 
conserved residue His 118 to Ala or to Glu [9] or to Gly [10] in 
E. coli EF-Tu also cause significant decreases in the affinity of 
EF-Tu for aa-tRNA. His us is in the immediate structural 
neighbourhood of Leu 12° and Gin 124 in the interface of do- 
mains I and III. Tapio et al. [5] found that the EF-Tu mutant 
Aa [32] has almost an order of magnitude lower affinity for 
Phe-tRNA phe than wild-type EF-Tu. Sequence analysis [13] 
revealed that the tufAa mutation leads to a GluazSLys change 
in domain III, also in the interface between domains I and III. 
In summary, all these cases show that the details of the amino 
acid sequences of the interface between domains I and III are 
important for the stability of the ternary complex. 
Perturbations of the binding of aminoacyl-tRNA to EF-Tu 
by amino acid substitutions in the interface between domains 
I and III cannot easily be explained by the recently deter- 
mined structure of the ternary complex of Phe-tRNA.EF- 
Tu.GDPNP [16]. In that structure the binding sites for the 
tRNA on EF-Tu are (i) the exposed surface of domain III 
which binds the T stem of tRNA, (ii) the junction of all three 
domains which forms a pocket for the 5'-phosphate of tRNA, 
and (iii) a narrow cleft between domains I and II which binds 
the 3' CCA-Phe end of tRNA. The surface of domain III 
which is in contact with the T stem of tRNA is not near 
the interface of domains I and III (Jens Nyborg, personal 
communication). However, we can envisage a number of 
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Fig. 3. (A-C) Scatchard plots to determine association constants (KA) for the interaction between aa-tRNA and EF-Tu.GTP (section 2). Tb 
and Tf are bound and free, respectively, Phe-tRNA Phe (see section 2 on how Tb and Tf are determined experimentally) and Tu0 is the total 
concentration of active EF-Tu. The intercept at the y-axis provides KA and the intercept at the x-axis gives how many molecules of Phe- 
tRNA Phe that are protected by one molecule of active EF-Tu. All intercepts at the x-axis are similar and close to 0.5, indicating that it takes 
two molecules of EF-Tu to protect one molecule of aa-tRNA from deacylation under those conditions• (A) Wild-type EF-Tu. GTP with or 
without kirromycin (100 mM). (B) The EF-Tu-GTP variants a6°Asp, and 16°Asn. (C) The EF-Tu.GTP variants 16°Cys, and 12°Gln. (D) Asso- 
ciation constant for the EF-Tu.GTP variant l~4Arg, determined by assuming that two molecules of EF-Tu.GTP protect one Phe-tRNA Phe 
from deacylation, as in the other five cases. The slope of the line gives the KA value. 
models which could, in principle, account for the perturba- 
tions caused by the substitutions. One possibility is that the 
substitutions in the domain I-III interface change the config- 
uration of EF-Tu, and that it is these larger scale structural 
alterations which slightly affect the relative spatial orientation 
of the three areas for the binding of aminoacyl-tRNA. A 
second possibility is that the substitutions affect the rather 
large conformational change which occurs when activating 
the GDP form of EF-Tu into its GTP form [1] in such a 
way as to shift the equilibrium towards the GDP form. 
The observations that kirromycin resistance often is asso- 
ciated with reduced affinity between EF -Tu .GTP  and aa- 
tRNA ([5,30], this work) suggest a causal relationship between 
resistance and affinity loss. To investigate this further we stu- 
died the strength of  Phe-tRNA Phe binding to wild-type EF- 
Tu.  GTP in the presence of kirromycin and found it to be 2- 
fold higher than without the drug (Fig. 3A). Pingoud et al. 
[27,29] found a 2-fold reduction in the affinity of Tyr- 
tRNA Tyr to EF-Tu.  GTP by the action of kirromycin. Taken 
together these results demonstrate small but significant effects 
of kirromycin on the stability of the wild-type ternary com- 
plex. The contrasting claim by Abrahams et al. [33], that 
kirromycin reduces the binding of aa-tRNA to EF -Tu .GTP  
by 3 orders of magnitude, may be due to their having EF- 
Tu • GDP, rather than EF-Tu.  GTP, in several of their assays. 
It is known that kirromycin enhances the GTPase activity of 
the ternary complex [17,33], so that the complex tends to fall 
apart on conversion of GTP to GDP on EF-Tu. To avoid this 
artifact special precautions must be taken. This was done in 
our experiments as well as in those of Pingoud et al. [27,29] by 
having a powerful energy regeneration system to keep the 
concentration of free GTP at a high level and the concentra- 
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Fig. 4. Determination of the missense rror frequency at different 
concentrations of EF-Tu.GTP for Leu-tRNA Le~ isoacceptors in 
bulk tRNA competing with Phe-tRNA ph~ for poly(U) programmed 
ribosomes ( ection 2). (A) Wild-type EF-Tu and the variants ~6°Asp, 
16°Asn and ]6°Cys. (B) Wild-type EF-TU and the variants 124Arg 
and 12°Gln. 
tion of free GDP at a very low value [25]. In this way the 
ternary complex could be stably maintained, in spite of the 
kirromycin induced GTPase activity. In the gel assays used by 
Abrahams et al. [33] there was no GTP regeneration to pre- 
vent an irreversible, kirrornycin induced, conversion of GTP 
to GDP in the ternary complex. 
The fact that wild-type EF-Tu. GTP can bind aa-tRNA and 
kirromycin simultaneously makes it very unlikely that they 
have overlapping binding sites. The basis of the causal rela- 
tionship between kirromycin resistance and reduced affinity 
for aa-tRNA may be the location of the mutations in the 
domain interface, a location which could plausibly affect the 
conformational switching of EF-Tu, reducing its affinity for 
both ligands. This interpretation would suggest hat though 
mutations to kirromycin resistance map to both sides of the 
domain I-III interface [13], the actual binding site of kirromy- 
cin might be elsewhere, for example on domain I, but be 
influenced by the interdomain teractions. 
To probe further the origin of kirromycin resistance, we 
measured the binding constants for the complex between 
Phe-tRNA phe and the kirromycin resistant EF-Tu mutants 
12°Gin and 16°Cys and found these not to be influenced by 
kirromycin. One possibility is that these EF-Tu variants have 
such a low affinity for kirromycin, that binding is negligible 
up to drug concentrations of 10 -4 M (section 2), and that the 
kirromycin resistance of these variants is due, at least par- 
tially, to their low affinity for the drug. 
We measured a 200-fold lower association constant for the 
binding of Phe-tRNA phe to EF-Tu. GDP than to EF-Tu. GTP, 
in accordance with previous results [7,27,29]. At the same 
time, EF-Tu.GDP did not protect Phe-tRNA phe from spon- 
taneous deacylation i  the presence of kirromycin. Since EF- 
Tu.GDP.kirromycin can bind aminoacyl-tRNA, there must 
exist a ternary complex configuration that does not protect 
the aminoacyl bond [29]. This configuration cannot be iden- 
tical with the ordinary ternary complex between EF-Tu. GTP 
and aa-tRNA, where there is good protection of aa-tRNA. 
From this we argue that the notion that kirromycin preserves 
EF-Tu in its GTP configuration as the ternary complex com- 
plex hits the A-site with concomitant GTP hydrolysis is an 
oversimplification: there must be a third structure of EF-Tu 
with very high affinity for the A-site (V. Dincbas and M. 
Ehrenberg, in preparation)• It is, furthermore, quite possible 
that mutant EF-Tu's that do not bind kirromycin in their free 
state, are able to do so when they are in the A-site. In such a 
case a weakened binding between EF-Tu and aa-tRNA would 
make it easier for EF-Tu.GDP.kirromycin complexes to 
leave the A-site, and this may be the reason why kirromycin 
resistance is frequently associated with low affinity for aa- 
tRNA binding to EF-Tu. 
Measurements of missense rrors for the different kirromy- 
cin resistant EF-Tu mutants reveal differential effects on their 
binding to different aminoacyl-tRNAs, as well as perturba- 
tions in their interaction with the ribosome• There is evidence 
for increased (12°Gin), for unchanged (124Arg) and for de- 
creased error levels (16°Cys) (Fig. 4A,B). In these three cases 
(and also for 16°Asp) missense rrors do not vary much with 
the concentration f EF-Tu. GTP, indicating that the affinities 
of Leu-tRNA L¢u and Phe-tRNA phe to EF-Tu.GTP are quite 
similar• In contrast, for 16°Asn missense rrors increase sig- 
nificantly with increasing EF-Tu concentrations (Fig. 4A). 
This indicates that for this factor mutant the binding of 
Leu-tRNA L¢" to EF-Tu. GTP is significantly weaker than the 
binding of Phe-tRNA phi. In the case of the mutant 16°Asn 
(Fig. 4A) the error level is lower than wild-type at low, and 
higher than wild-type at high, EF-Tu concentrations• This 
shows, firstly, that Leu-tRNA L~u has a significantly lower af- 
finity to the 16°Asn variant han does Phe-tRNA ehe. The ami- 
no acid change has in this case reduced the affinity of Phe- 
tRNA Phe for EF-Tu about 2-fold (Table 1) but the affinity of 
Leu-tRNA Le" must be reduced much further. It shows, sec- 
ondly, that for this EF-Tu variant a Leu-tRNA Lc" containing 
ternary complex competes better with a Phe-tRNA phe ternary 
complex for the ribosomal A-site than when EF-Tu is wild- 
type. The enhanced missense rrors at excess EF-Tu concen- 
trations may reflect a general stabilization of the binding be- 
tween EF-Tu and the A-site by the Tyr--* Asn change at posi- 
tion 160 (cf. [34,35]). A similar type of argument suggests that 
the Tyr -~ Cys change at the same position leads to a universal 
destabilization f ternary complex binding to the A-site caus- 
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ing reduced (Fig. 4A), rather than enhanced, missense lev- 
els. 
One mutant, Tyr16°Cys, also has a significantly enhanced 
exchange rate of GDP on EF-Tu. Interestingly, the substitu- 
tion HisllSGly also alters the interaction between guanine 
nucleotide and EF-Tu, decreasing EF-Tu's intrinsic GTPase 
activity in the absence, but increasing it in the presence of aa- 
tRNA [10]. Thus, substitutions in the domain interface, many 
of which apparently decrease the affinity of aa-tRNA for EF- 
Tu, are in some cases also associated with alterations in the 
interaction between EF-Tu and the bound guanine nucleotide. 
Current structural information [1,2,31] does not indicate any 
direct interaction between these residues and the guanine nu- 
cleotide, suggesting that these effects are indirect. 
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